Effectiveness of acupuncture and related therapies for palliative care of cancer: overview of systematic reviews
Wu et al. · Scientific Reports · 2015
Evidence Level
MODERATEOBJECTIVE
To evaluate the effectiveness and safety of acupuncture and related therapies in the palliative care of oncology patients
WHO
Patients with any type of cancer in palliative care
DURATION
Analysis of 23 systematic reviews published between 2005-2014
POINTS
Various points according to the individual protocols of the primary studies
🔬 Study Design
Acupuncture and related therapies
n=8696
Needle acupuncture, electroacupuncture, moxibustion, TENS
Controls
n=8696
Conventional care, sham acupuncture, or no treatment
📊 Results in numbers
Effective for cancer-related fatigue
Effective for chemotherapy-induced nausea and vomiting
Effective for leukopenia
Conflicting evidence for cancer pain
Serious adverse events
📊 Outcome Comparison
Methodological quality of reviews (AMSTAR)
This broad analysis shows that acupuncture may be a safe and effective option for some cancer symptoms, particularly fatigue, chemotherapy-induced nausea, and low white blood cell counts. For cancer pain, results are mixed and additional research is needed.
Article summary
Plain-language narrative summary
This comprehensive overview of systematic reviews represents the most complete assessment of the effectiveness of acupuncture and related therapies in oncology palliative care. The study analyzed 23 systematic reviews published between 2005 and 2014, encompassing evidence from 248 primary studies with 17,392 participants, offering a broad perspective on the role of these integrative therapies in the management of cancer-related symptoms. The methodology was rigorous, drawing on four international and three Chinese databases, with searches conducted from database inception through July 2014. The methodological quality of the reviews was assessed using the AMSTAR instrument, revealing satisfactory performance on most criteria, particularly in the conduct of comprehensive searches and the assessment of the scientific quality of included studies.
The findings demonstrate consistent evidence for the effectiveness of acupuncture in three main areas. For cancer-related fatigue, meta-analyses showed a significant reduction when acupuncture was combined with education compared with conventional care. In the prevention of chemotherapy-induced nausea and vomiting, multiple reviews confirmed the benefits of acupuncture, particularly in reducing the proportion of patients with acute vomiting. For chemotherapy-induced leukopenia, the evidence suggests that acupuncture may promote an increase in white blood cell counts.
However, the results were conflicting for other important conditions. In the management of cancer pain, ten systematic reviews reported divergent conclusions, with some meta-analyses finding no significant differences between acupuncture and controls, although well-conducted individual studies showed benefits with auricular acupuncture. For hot flashes in breast and prostate cancer patients, results varied according to the assessment period, with benefits more evident during treatment. The safety analysis was reassuring, with only minor adverse events reported, such as local bleeding, skin irritation, and transient discomfort.
No serious adverse events requiring medical intervention were documented in any of the studies analyzed. This important finding reinforces the favorable safety profile of acupuncture in the oncology setting. The clinical implications are significant. Acupuncture may be considered as a complementary therapy for cancer-related fatigue, particularly when conventional management is insufficient, a situation widely recognized in clinical practice.
For chemotherapy-induced nausea and vomiting, it may be used as an adjunct to conventional antiemetic protocols. In leukopenia, it offers an alternative when antibacterial/antifungal prophylaxis is not recommended. Identified limitations include significant heterogeneity in the acupuncture protocols used, variations in outcome assessment methods, and inconsistent methodological quality of the primary studies. Many studies had problems with allocation concealment and blinding, limiting the reliability of the results.
The lack of standardization in treatment protocols makes it difficult to determine which specific techniques are most effective.
Strengths
- 1Comprehensive search across multiple databases including Chinese sources
- 2Rigorous methodological quality assessment using a validated instrument (AMSTAR)
- 3Large combined sample of 17,392 participants
- 4Separate analysis by type of therapy and study design
- 5Comprehensive safety assessment with no serious adverse events
Limitations
- 1Significant heterogeneity in acupuncture protocols across studies
- 2Inconsistent methodological quality of the included primary studies
- 3Important variations in outcome assessment methods
- 4No review adequately assessed publication bias
- 5Lack of detail on specific protocols precluding more refined analyses
Expert Commentary
Prof. Dr. Hong Jin Pai
PhD in Sciences, University of São Paulo
▸ Clinical Relevance
In the context of oncology palliative care, the search for interventions that reduce treatment toxicity without adding to the pharmacologic burden is constant. This overview of systematic reviews, gathering 17,392 participants across 248 primary studies, provides the most comprehensive evidence base available to guide the integration of acupuncture into supportive oncology. The findings for fatigue, chemotherapy-induced nausea and vomiting, and leukopenia address concrete clinical demands: patients on chemotherapy regimens with incomplete antiemetic control, patients with refractory fatigue that compromises function and treatment adherence, and patients with leukocyte decline in settings where antimicrobial prophylaxis has limited applicability. The safety profile confirmed — zero serious adverse events in a sample of this size — is robust data supporting use in clinically and immunologically vulnerable populations, where the margin for complications is narrow.
▸ Notable Findings
Three findings deserve particular attention. The first is the consistency of evidence for chemotherapy-induced nausea and vomiting — a particularly relevant outcome because antiemetic control, even with modern regimens combining 5-HT3 and NK1 antagonists, remains incomplete in a significant proportion of patients. The second is the positive signal for leukopenia: the possibility that acupuncture modulates leukocyte count represents, if confirmed, a mechanism of immunologic interest that goes beyond symptomatic management. The third — perhaps the most provocative — is the divergence of results for cancer pain across ten systematic reviews, with benefit suggested particularly for auricular acupuncture in some well-conducted individual studies. This heterogeneity does not invalidate the field; it signals that protocol refinement and patient subgroup selection are determining variables that future research must address.
▸ From My Experience
At the HC-FMUSP Pain Center, we have integrated acupuncture into supportive oncology protocols for many years, and what this work documents on a large scale is consistent with what we observe routinely. For chemotherapy-induced nausea, PC-6 (Neiguan, 內關) is our first choice, and response is usually perceptible within the first sessions — patients often report it after the second or third treatment. For fatigue, the picture is different: improvement tends to be more gradual, and patients need to be counseled not to expect an immediate response; I usually observe consistent change between the fifth and eighth sessions. In leukopenia, we use protocols with points on the Stomach and Spleen meridians, combined with moxibustion, and laboratory follow-up at 3-4 weeks usually shows a recovery trend. The patient profile that responds best to acupuncture in the oncology setting, in my experience, is one with structured multidisciplinary support — it does not work as an isolated intervention, and its potency is amplified when combined with supervised physical exercise and appropriate psychosocial care.
Full original article
Read the full scientific study
Scientific Reports · 2015
DOI: 10.1038/srep16776
Access original articleScientific Review
Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories